{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:32:27Z","timestamp":1788391947364,"version":"build-2803163510"},"update-to":[{"DOI":"10.12688\/gatesopenres.13086.1","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000}}],"reference-count":44,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gates Foundation","award":["OPP1053230"],"award-info":[{"award-number":["OPP1053230"]}]}],"content-domain":{"domain":["gatesopenresearch.org"],"crossmark-restriction":false},"short-container-title":["Gates Open Res"],"abstract":"<ns3:p>Trachoma is a neglected tropical disease and the leading infectious cause of blindness worldwide. The current World Health Organization goal for trachoma is elimination as a public health problem, defined as reaching a prevalence of trachomatous inflammation-follicular below 5% in children (1-9 years) and a prevalence of trachomatous trichiasis in adults below 0.2%. Current targets to achieve elimination were set to 2020 but are being extended to 2030. Mathematical and statistical models suggest that 2030 is a realistic timeline for elimination as a public health problem in most trachoma endemic areas. Although the goal can be achieved, it is important to develop appropriate monitoring tools for surveillance after having achieved the elimination target to check for the possibility of resurgence. For this purpose, a standardized serological approach or the use of multiple diagnostics in complement would likely be required.<\/ns3:p>","DOI":"10.12688\/gatesopenres.13086.2","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T10:25:06Z","timestamp":1615458306000},"page":"1721","update-policy":"https:\/\/doi.org\/10.12688\/gatesopenres.crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Insights from mathematical modelling and quantitative analysis on the proposed 2030 goals for trachoma"],"prefix":"10.12688","volume":"3","author":[{"name":"NTD Modelling Consortium discussion group on trachoma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"ref-1","article-title":"Trachoma control: a guide for programme managers.","author":"A Solomon","year":"2006"},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"223-229","DOI":"10.1016\/S0140-6736(03)13914-1","article-title":"Trachoma.","volume":"362","author":"D Mabey","year":"2003","journal-title":"Lancet."},{"key":"ref-3","article-title":"WHO validates Myanmar for eliminating trachoma as a public health problem."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"572-576","DOI":"10.1038\/8451","article-title":"Global elimination of trachoma: how frequently should we administer mass chemotherapy?","volume":"5","author":"T Lietman","year":"1999","journal-title":"Nat Med."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"S275-S280","DOI":"10.1093\/cid\/ciy004","article-title":"Models of Trachoma Transmission and Their Policy Implications: From Control to Elimination.","volume":"66","author":"T Lietman","year":"2018","journal-title":"Clin Infect Dis."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"48-55","DOI":"10.1016\/j.epidem.2017.01.007","article-title":"Probabilistic forecasts of trachoma transmission at the district level: A statistical model comparison.","volume":"18","author":"A Pinsent","year":"2017","journal-title":"Epidemics."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2350-7-40","article-title":"A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection.","volume":"7","author":"A Natividad","year":"2006","journal-title":"BMC Med Genet."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"e0003610","DOI":"10.1371\/journal.pntd.0003610","article-title":"Mass drug administration for trachoma: how long is not long enough?","volume":"9","author":"V Jimenez","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"e507","DOI":"10.1371\/journal.pntd.0000507","article-title":"Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution.","volume":"3","author":"T Lakew","year":"2009","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"143-151","DOI":"10.1016\/S0140-6736(11)61515-8","article-title":"Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.","volume":"379","author":"T Gebre","year":"2012","journal-title":"Lancet."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"1-48","DOI":"10.1016\/bs.apar.2016.06.002","article-title":"Mathematical Modelling of Trachoma Transmission, Control and Elimination.","volume":"94","author":"A Pinsent","year":"2016","journal-title":"Adv Parasitol."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"721-725","DOI":"10.1001\/jama.292.6.721","article-title":"Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.","volume":"292","author":"M Melese","year":"2004","journal-title":"JAMA."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"709-21","DOI":"10.1111\/ijn.12374","article-title":"Interventions for the treatment of trachoma: an overview of Cochrane systematic reviews.","volume":"20","author":"C Lockwood","year":"2014","journal-title":"Int J Nurs Pract."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"CD003659","DOI":"10.1002\/14651858.CD003659.pub4","article-title":"Face washing promotion for preventing active trachoma.","volume":"2015","author":"H Ejere","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"75-84","DOI":"10.1016\/j.inhe.2011.03.004","article-title":"Efficacy of latrine promotion on emergence of infection with ocular Chlamydia trachomatis after mass antibiotic treatment: a cluster-randomized trial.","volume":"3","author":"N Stoller","year":"2011","journal-title":"Int Health."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"e1002633","DOI":"10.1371\/journal.pmed.1002633","article-title":"Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).","volume":"15","author":"J Keenan","year":"2018","journal-title":"PLoS Med."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"e0006478","DOI":"10.1371\/journal.pntd.0006478","article-title":"Identifying a sufficient core group for trachoma transmission.","volume":"12","author":"T Lietman","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12916-016-0614-6","article-title":"Enhanced antibiotic distribution strategies and the potential impact of facial cleanliness and environmental improvements for the sustained control of trachoma: a modelling study.","volume":"14","author":"A Pinsent","year":"2016","journal-title":"BMC Med."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"11:1-11:6","DOI":"10.22360\/SpringSim.2016.ADS.020","article-title":"Prospects for Trachoma Elimination Through Mass Treatment Targeted at Children.","author":"R Ying","year":"2016"},{"key":"ref-20","article-title":"Sanitation, Water, and Instruction in Face-washing for Trachoma (SWIFT)."},{"key":"ref-21","article-title":"Trachoma Elimination Study by Focused Antibiotic (TESFA)."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"e0006531","DOI":"10.1371\/journal.pntd.0006531","article-title":"Optimising sampling regimes and data collection to inform surveillance for trachoma control.","volume":"12","author":"A Pinsent","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"e0007605","DOI":"10.1371\/journal.pntd.0007605","article-title":"The costs of monitoring trachoma elimination: Impact, surveillance, and trachomatous trichiasis (TT)-only surveys.","volume":"13","author":"R Stelmach","year":"2019","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.12688\/wellcomeopenres.13423.2","article-title":"Clinical signs of trachoma are prevalent among Solomon Islanders who have no persistent markers of prior infection with Chlamydia trachomatis [version 2; peer review: 2 approved].","volume":"3","author":"R Butcher","year":"2018","journal-title":"Wellcome Open Res."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"512-3","DOI":"10.1001\/archophthalmol.2011.46","article-title":"Slow resolution of clinically active trachoma following successful mass antibiotic treatments.","volume":"129","author":"J Keenan","year":"2011","journal-title":"Arch Ophthalmol."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"e0004462","DOI":"10.1371\/journal.pntd.0004462","article-title":"Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program.","volume":"10","author":"B Pant","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"e399-e407","DOI":"10.1016\/S1473-3099(18)30159-2","article-title":"Advancing the public health applications of Chlamydia trachomatis serology.","volume":"18","author":"S Woodhall","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.1038\/s41467-018-07852-0","article-title":"The utility of serology for elimination surveillance of trachoma.","volume":"9","author":"A Pinsent","year":"2018","journal-title":"Nat Commun."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"e376","DOI":"10.1371\/journal.pntd.0000376","article-title":"Reduction and return of infectious trachoma in severely affected communities in Ethiopia.","volume":"3","author":"T Lakew","year":"2009","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s13071-015-1133-6","article-title":"Possible changes in the transmissibility of trachoma following MDA and transmission reduction: implications for the GET2020 goals.","author":"M Gambhir","year":"2015","journal-title":"Parasit Vectors."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"S519-S524","DOI":"10.1093\/infdis\/jiz691","article-title":"Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution.","volume":"221","author":"W Godwin","year":"2020","journal-title":"J Infect Dis."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/s13071-015-1115-8","article-title":"Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection.","volume":"8","author":"F Liu","year":"2015","journal-title":"Parasit Vectors."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"141-156","DOI":"10.1007\/978-1-4419-6064-1_10","article-title":"Modelling trachoma for control programmes.","volume":"673","author":"M Gambhir","year":"2010","journal-title":"Adv Exp Med Biol."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"e0006270","DOI":"10.1371\/journal.pntd.0006270","article-title":"Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.","volume":"12","author":"T Astale","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"493-501","DOI":"10.1111\/tmi.13208","article-title":"Population coverage and factors associated with participation following a mass drug administration of azithromycin for trachoma elimination in Amhara, Ethiopia.","volume":"24","author":"C Ebert","year":"2019","journal-title":"Trop Med Int Health."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"56-66","DOI":"10.1016\/j.epidem.2017.02.002","article-title":"Measuring and modelling the effects of systematic non-adherence to mass drug administration.","volume":"18","author":"L Dyson","year":"2017","journal-title":"Epidemics."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"913-922","DOI":"10.1093\/aje\/kws345","article-title":"Using a nonparametric multilevel latent Markov model to evaluate diagnostics for trachoma.","volume":"177","author":"A Koukounari","year":"2013","journal-title":"Am J Epidemiol."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"6133-6137","DOI":"10.1167\/iovs.11-7419","article-title":"How reliable are tests for trachoma?--a latent class approach.","volume":"52","author":"C See","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"e0005080","DOI":"10.1371\/journal.pntd.0005080","article-title":"The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment.","volume":"10","author":"A Ramadhani","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"18532","DOI":"10.1038\/srep18532","article-title":"Serological Measures of Trachoma Transmission Intensity.","volume":"5","author":"D Martin","year":"2015","journal-title":"Sci Rep."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"e0003555","DOI":"10.1371\/journal.pntd.0003555","article-title":"Serology for trachoma surveillance after cessation of mass drug administration.","volume":"9","author":"D Martin","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"1188-1194","DOI":"10.3201\/eid2407.171928","article-title":"Integrated Serologic Surveillance of Population Immunity and Disease Transmission.","volume":"24","author":"B Arnold","year":"2018","journal-title":"Emerg Infect Dis."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"15040","DOI":"10.1038\/s41598-017-15056-7","article-title":"Serology reflects a decline in the prevalence of trachoma in two regions of The Gambia.","volume":"7","author":"S Migchelsen","year":"2017","journal-title":"Sci Rep."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12879-019-3935-1","article-title":"Understanding the spatial distribution of trichiasis and its association with trachomatous inflammation-follicular.","volume":"19","author":"R Flueckiger","year":"2019","journal-title":"BMC Infect Dis."}],"container-title":["Gates Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/gatesopenresearch.org\/articles\/3-1721\/v2\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/gatesopenresearch.org\/articles\/3-1721\/v2\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/gatesopenresearch.org\/articles\/3-1721\/v2\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T10:40:21Z","timestamp":1620643221000},"score":1,"resource":{"primary":{"URL":"https:\/\/gatesopenresearch.org\/articles\/3-1721\/v2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":44,"URL":"https:\/\/doi.org\/10.12688\/gatesopenres.13086.2","relation":{"has-review":[{"id-type":"doi","id":"10.21956\/gatesopenres.14449.r30502","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/gatesopenres.14449.r30503","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/gatesopenres.14449.r30502","asserted-by":"object"},{"id-type":"doi","id":"10.21956\/gatesopenres.14449.r30503","asserted-by":"object"}]},"ISSN":["2572-4754"],"issn-type":[{"value":"2572-4754","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"assertion":[{"value":"Indexed","URL":"https:\/\/gatesopenresearch.org\/articles\/3-1721\/v2#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.21956\/gatesopenres.14449.r30503, Isobel M. Blake, Department of Infectious Disease Epidemiology, Imperial College London, London, UK, 10 May 2021, version 2, indexed","URL":"https:\/\/gatesopenresearch.org\/articles\/3-1721\/v2#referee-response-30503","order":0,"name":"referee-response-30503","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.21956\/gatesopenres.14449.r30502, Lisa A. Rotondo, Rebecca Flueckiger, RTI International, Washington, DC, USA, 06 Apr 2021, version 2, indexed","URL":"https:\/\/gatesopenresearch.org\/articles\/3-1721\/v2#referee-response-30502","order":1,"name":"referee-response-30502","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This work was supported by the Bill & Melinda Gates Foundation through the NTD Modelling Consortium (grant number OPP1184344). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}